TGF-β1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: An investigation of multiple known DNA sequence variants

American Journal of Kidney Diseases

Volumn 41, Issue 1, 2003, Pages 22-28

  Ng, Daniel P K ^a,b   Warram, James H ^a,b   Krolewski, Andrzej S ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cytokine; Glomerulosclerosis; Polymorphism

Indexed keywords

ARGININE; CYTOKINE; CYTOSINE; ISOLEUCINE; LEUCINE; PROLINE; THREONINE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA SEQUENCE; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE LOCUS; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLOMERULOSCLEROSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PROTEINURIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0037228097     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50011     Document Type: Article

References (33)

1. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease - The case for transforming growth factor-β as a key mediator. Diabetes 44:1139-1146, 1995
2. Nakamura T, Fukui M, Ebihara I, et al: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42:450-456, 1993
3. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A 90:1814-1818, 1993
4. Bertoluci MC, Schmid H, Lachat JJ, Coimbra TM: Transforming growth factor-beta in the development of rat diabetic nephropathy. A 10-month study with insulin-treated rats. Nephron 74:189-196, 1996
5. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
6. Ziyadeh FN, Hoffman BB, Han DC, et al: Long-term prevention of renal insufficiency, excess matrix gene expression and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A 97:8015-8020, 2000
7. Inoki K, Haneda M, Maeda S, Koya D, Kikkawa R: TGF-beta1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. Kidney Int 55:1704-1712, 1999
8. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P: Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802-1814, 1995
9. Henry DN, Busik JV, Brosius FC III, Heilig CW: Glucose transporters control gene expression of aldose reductase, PKC-alpha, and GLUT1 in mesangial cells in vitro. Am J Physiol 277:F97-F104, 1999
10. Fujii D, Brissenden JE, Derynck R, Francke U: Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet 12:281-288, 1986
11. Derynck R, Rhee L, Chen EY, Tilburg AV: Intronexon structure of the human transforming growth factor-β precursor gene. Nucleic Acids Res 15:3188-3189, 1987
12. Cambien F, Ricard S, Troesch A, et al: Polymorphisms of the transforming growth factor-beta1 gene in relation to myocardial infarction and blood pressure: The Etude Cas-Temoin de I'Infarctus du Myocarde (ECTIM) Study. Hypertension 28:881-887, 1996
13. Awad MR, El-Garnel A, Hasleton P, et al: Genotypic variation in the transforming growth factor-β1 gene. Transplantation 66:1014-1020, 1998
14. Gentry LE, Webb NR, Lim GJ, et al: Type 1 transforming growth factor beta: Amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells. Mol Cell Biol 7:3418-3427, 1987
15. Langdahl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF: A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 20:289-294, 1997
16. Pociot F, Hansen PM, Karlsen AE, Langdahl BL, Johannesen J, Nerup J: TGF-β1 gene mutations in insulin-dependent diabetes mellitus and diabetic nephropathy. J Am Soc Nephrol 9:2302-2307, 1998
17. Akai Y, Sato H, Ozaki H, Iwano M, Dohi Y, Kanauchi M: Association of transforming growth factor-beta1 T29C polymorphism with the progression of diabetic nephropathy. Am J Kidney Dis 38:S182-S185, 2001 (suppl 1)
18. Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of type 1 diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 7:930-937, 1996
19. Wood NAP, Thomson SC, Smith RM, Bidwell JL: Identification of human TGF-β1 signal (leader) sequence polymorphisms by PCR-RFLP. J Immunol Methods 234:117-122, 2000
20. Araki SI, Moczulski DK, Hanna L, Scott LJ, Warram JH, Krolewski AS: APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: Results of case-control and family based studies. Diabetes 49:2190-2195, 2000
21. Lyons RM, Gentry LE, Purchio AF, Moses HL: Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol 110: 1361-1367, 1990
22. Rogus JJ, Warram JH, Krolewski AS: Genetic studies of late diabetic complications: The overlooked importance of diabetes duration before complication onset. Diabetes 51:1655-1662, 2002
23. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE: Transforming growth factor-β1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A 97:3479-3484, 2000
24. Morrisey K, Evans RA, Wakefield L, Phillips AO: Translational regulation of renal proximal tubular epithelial cell transforming growth factor-β1 generation by insulin. Am J Pathol 159:1905-1915, 2001
25. Kim SJ, Glick A, Sporn MB, Roberts AB: Characterization of the promoter region of the human transforming growth factor-β1 gene. J Biol Chem 264:402-408, 1989
26. Weigert C, Sauer U, Brodbeck K, Pfeiffer A, Haring HU, Schleicher ED: AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-β1 promoter in mesangial cells. J Am Soc Nephrol 11:2007-2016, 2000
27. Kim SJ, Denhez F, Kim KY, Holt JT, Sporn MB, Roberts AB: Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J Biol Chem 264:19373-19378, 1989
28. Scotto L, Vaduva PI, Wager RE, Assoian RK: Type β1 transforming growth factor gene expression - A corrected mRNA structure reveals a downstream phorbol ester responsive element in human cells. J Biol Chem 265:2203-2208, 1990
29. Streuli CH, Schmidhauser C, Kobrin M, Bissell MJ, Derynick R: Extracellular matrix regulates expression of the TGF-β1 gene. J Cell Biol 120:253-260, 1993
30. Kim SJ, Jeang KT, Glick AB, Sporn MB, Roberts AB: Promoter sequences of the human transforming growth factor-β1 gene responsiveness to transforming growth factor-β1 autoinduction. J Biol Chem 264:7041-7045, 1989
31. Kim SJ, Angel P, Lafyatis R, et al: Autoinduction of transforming growth factor-β1 is mediated by the AP-1 complex. Mol Cell Biol 10: 1492-1497, 1990
32. Isono M, Mogyorosi A, Han DC, Hoffman BB, Ziyadeh FN: Stimulation of TGF-β type II receptor by high glucose in mouse mesangial cells and in diabetic kidney. Am J Physiol Ren Physiol 278:F830-F838, 2000
33. Hong SW, Isono M, Chen S, Iglesias-De La Cruz MC, Han DC, Ziyadeh FN: Increased glomerular and tubular expression of transforming growth factor-beta1, its type 11 receptor, and activation of the Smad signalingpathway in the db/db mouse. Am J Pathol 158:1653-1663, 2001